Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > How can we afford
View:
Post by rhdmd on Jun 05, 2013 8:26pm

How can we afford

the Trials cost of Urocidin? Note under this deal, we are responsible for the development cost and manufacturing cost. (in Canada, Mexico and S. Africa) Before we can sell it to other countries, we need the pproval first. And the only foreseeable trials are the ones in Canada. That means we are responsible for this cost. I guess we must sell AH now to raise the fund. And you can forget the dividend. All will go towards this gamble in Urocidin. 

Unless, we can come up with a U.S. company that is willing to fund the FDA trials in U.S. And the price (rights assignment) won't be cheap.

Any guess how much we can get the SP to even if all works out?

Comment by Nohandledzep on Jun 05, 2013 8:43pm
Doc, I wouldn't expect someone to fully cover ongoing Urocidin manufacturing and development costs for Canada, Mexico and SA, but I would expect that they would pay something.   Paladin has more or less taken on the same role of Vedco with Immunocidin. Call us when it's approved, and we'll sell it. There is zero risk of their part.   Bioniche has stated, on many occasions ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse